Stocks
ANI Pharmaceuticals (ANIP) ROE US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 2.86% | -11.5% | -11.9% | -14.1% | 4.34% | -1.65% | ||
| Changes by years, y/y, % | -5pp | -14pp | 0pp | -2pp | +18pp | -11.2% | |||
ANI Pharmaceuticals. ROE, %
ANI Pharmaceuticals. ROE, changes, pp
ANI Pharmaceuticals (ANIP) ROE US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | 2.94% | 4.34% | 7.87% | 5.93% | -1.65% | -1.65% | |
| Changes by years, y/y, % | +31pp | +18pp | +16pp | +7pp | -5pp | |||
| Changes by quarters, q/q, % | +4pp | +1pp | +4pp | -2pp | -8pp | |||
